These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18751392)

  • 21. [Thymidylate synthase activity after preoperative administration of 5-FU in patients with gastric or colorectal cancer].
    Arima S; Tachikawa D; Kawahara K; Futami K
    Gan To Kagaku Ryoho; 2000 May; 27(5):703-10. PubMed ID: 10832438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.
    Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M
    Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine.
    Lynch TP; Cass CE; Paterson AR
    J Supramol Struct; 1977; 6(3):363-74. PubMed ID: 145516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
    Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
    Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study.
    Fanciullino R; Evrard A; Cuq P; Giacometti S; Peillard L; Mercier C; Aubert C; Milano G; Ciccolini J
    Anticancer Drugs; 2006 Apr; 17(4):463-70. PubMed ID: 16550005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
    Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
    Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer.
    Fan CW; Fan HA; Hsu SH; Chan CC; Chen SY; Hsu YH; Chan EC
    Cancer Lett; 2004 Oct; 214(2):181-8. PubMed ID: 15363544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
    Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
    Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
    Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
    Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.
    Murata S; Adachi M; Kioi M; Torigoe S; Ijichi K; Hasegawa Y; Ogawa T; Bhayani MK; Lai SY; Mitsudo K; Tohnai I
    Anticancer Res; 2011 Sep; 31(9):2893-8. PubMed ID: 21868535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.
    Ijichi K; Adachi M; Ogawa T; Hasegawa Y; Murakami S
    Anticancer Res; 2014 Jun; 34(6):2907-11. PubMed ID: 24922653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.
    Merkenschlager M; Kardamakis D; Rawle FC; Spurr N; Beverley PC
    Immunology; 1988 Jan; 63(1):125-31. PubMed ID: 3338817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance in colon cancer.
    Gorlick R; Bertino JR
    Semin Oncol; 1999 Dec; 26(6):606-11. PubMed ID: 10606253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
    Brody JR; Hucl T; Costantino CL; Eshleman JR; Gallmeier E; Zhu H; van der Heijden MS; Winter JM; Wikiewicz AK; Yeo CJ; Kern SE
    Cancer Res; 2009 Feb; 69(3):984-91. PubMed ID: 19155291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
    Landis DM; Heindel CC; Loeb LA
    Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Li T; Gao F; Zhang XP
    Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
    Taverna P; Rendahl K; Jekic-McMullen D; Shao Y; Aardalen K; Salangsang F; Doyle L; Moler E; Hibner B
    Biochem Pharmacol; 2007 Jan; 73(1):44-55. PubMed ID: 17046720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.